Supplements work more modestly, nudging your bodys own hormone production and supporting weight management as part of a larger healthy lifestyle
Most gastrointestinal symptoms are mild to moderate in severity and tend to diminish over time as the body adjusts to the medication, particularly when dose escalation follows the recommended gradual titration schedule
Peptide YY(336) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys
That said, there is some real absorption data
Microdosing below 2.5 mg can reasonably be expected to produce lower rates of these GI symptoms, since they correlate primarily with GLP-1 receptor activation and the resulting slowing of gastric motility
Diabetes Obes Metab 18:11761190 Pocai A, Carrington PE, Adams JR et al (2009) Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice